Protonix
NDC Package 67296-0029-7

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Protonix is pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). Marketed by Redpharm Drug, Inc., this product is identified by NDC 67296-0029 and is authorized under FDA application NDA020987.

Identification & Billing

NDC Package Code
67296-0029-7
Package Description
14 TABLET, DELAYED RELEASE in 1 BOTTLE
Product Code
11-Digit Billing Format
67296002907
RxNorm Crosswalk
  • RxCUI: 284400 - Protonix 40 MG Delayed Release Oral Tablet
  • RxCUI: 284400 - pantoprazole 40 MG Delayed Release Oral Tablet [Protonix]
  • RxCUI: 284400 - Protonix 40 MG (pantoprazole sodium sesquihydrate 45.1 MG) Delayed Release Oral Tablet
  • RxCUI: 314200 - pantoprazole sodium 40 MG Delayed Release Oral Tablet
  • RxCUI: 314200 - pantoprazole 40 MG Delayed Release Oral Tablet

Clinical Specifications

Proprietary Name
Protonix Delayed-release
Dosage Form
-
Usage Information
Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

Regulatory & Marketing

Labeler Name
Redpharm Drug, Inc.
FDA Application #
NDA020987
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
05-01-2000
Listing Expiration
12-31-2023
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67296-0029-7 identifies a specific commercial package of 14 tablet, delayed release in 1 bottle of Protonix Delayed-release, labeled by Redpharm Drug, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Redpharm Drug, Inc. on May 01, 2000. The current certification is valid through December 31, 2023.

What are the primary indications for this medication?

Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

How is this Redpharm Drug, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67296002907. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
67296-0029-7
11-Digit CMS (5-4-2)
67296-0029-07

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.